372 related articles for article (PubMed ID: 31676843)
1. Liposomal delivery of CRISPR/Cas9.
Zhen S; Li X
Cancer Gene Ther; 2020 Aug; 27(7-8):515-527. PubMed ID: 31676843
[TBL] [Abstract][Full Text] [Related]
2. Effect of surface properties on liposomal siRNA delivery.
Xia Y; Tian J; Chen X
Biomaterials; 2016 Feb; 79():56-68. PubMed ID: 26695117
[TBL] [Abstract][Full Text] [Related]
3. New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.
van Hees M; Slott S; Hansen AH; Kim HS; Ji HP; Astakhova K
Mol Ther; 2022 Jan; 30(1):32-46. PubMed ID: 34091053
[TBL] [Abstract][Full Text] [Related]
4. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
5. Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.
Sun Q; Zhang H; Ding F; Gao X; Zhu Z; Yang C
Int J Pharm; 2024 Mar; 652():123845. PubMed ID: 38266942
[TBL] [Abstract][Full Text] [Related]
6. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.
Li L; Song L; Liu X; Yang X; Li X; He T; Wang N; Yang S; Yu C; Yin T; Wen Y; He Z; Wei X; Su W; Wu Q; Yao S; Gong C; Wei Y
ACS Nano; 2017 Jan; 11(1):95-111. PubMed ID: 28114767
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry MO; Abdel-Megeed RM
PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
[TBL] [Abstract][Full Text] [Related]
8. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Wang L; Zheng W; Liu S; Li B; Jiang X
Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
[TBL] [Abstract][Full Text] [Related]
10. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
13. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
[TBL] [Abstract][Full Text] [Related]
14. Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing.
Xu Y; Liu R; Dai Z
Nanoscale; 2020 Oct; 12(41):21001-21014. PubMed ID: 33078813
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology.
Schuh RS; Poletto É; Fachel FNS; Matte U; Baldo G; Teixeira HF
J Colloid Interface Sci; 2018 Nov; 530():243-255. PubMed ID: 29982016
[TBL] [Abstract][Full Text] [Related]
16. Efficient Intracellular Delivery of CRISPR-Cas Ribonucleoproteins through Receptor Mediated Endocytosis.
Rouet R; Christ D
ACS Chem Biol; 2019 Mar; 14(3):554-561. PubMed ID: 30779874
[TBL] [Abstract][Full Text] [Related]
17. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
[TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced delivery of liposomal drugs for effective treatment of glioblastoma multiforme.
Han Y; Park JH
Drug Deliv Transl Res; 2020 Dec; 10(6):1876-1887. PubMed ID: 32367425
[TBL] [Abstract][Full Text] [Related]
19. Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors.
Jubair L; Fallaha S; McMillan NAJ
Mol Ther; 2019 Dec; 27(12):2091-2099. PubMed ID: 31537455
[TBL] [Abstract][Full Text] [Related]
20. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System.
Aksoy YA; Yang B; Chen W; Hung T; Kuchel RP; Zammit NW; Grey ST; Goldys EM; Deng W
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52433-52444. PubMed ID: 33174413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
